$407.60
1.25% yesterday
NYSE, Nov 25, 10:03 pm CET
ISIN
US0367521038
Symbol
ELV

Elevance Health Stock price

$407.60
-17.67 4.16% 1M
-113.81 21.83% 6M
-63.96 13.56% YTD
-69.81 14.62% 1Y
-17.19 4.05% 3Y
+113.71 38.69% 5Y
+280.45 220.57% 10Y
NYSE, Closing price Mon, Nov 25 2024
+5.05 1.25%
ISIN
US0367521038
Symbol
ELV
Sector

Key metrics

Market capitalization $94.53b
Enterprise Value $113.92b
P/E (TTM) P/E ratio 14.86
EV/FCF (TTM) EV/FCF 130.79
EV/Sales (TTM) EV/Sales 0.65
P/S ratio (TTM) P/S ratio 0.54
P/B ratio (TTM) P/B ratio 2.16
Dividend yield 1.60%
Last dividend (FY24) $6.52
Revenue growth (TTM) Revenue growth 3.20%
Revenue (TTM) Revenue $174.02b
EBIT (operating result TTM) EBIT $9.20b
Free Cash Flow (TTM) Free Cash Flow $871.00m
EPS (TTM) EPS $27.43
P/E forward 15.15
P/S forward 0.54
EV/Sales forward 0.65
Short interest 1.23%
Show more

Is Elevance Health a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Elevance Health Stock Analysis

Unlock Scores for Free

Analyst Opinions

22 Analysts have issued a Elevance Health forecast:

17x Buy
77%
4x Hold
18%
1x Sell
5%

Analyst Opinions

22 Analysts have issued a Elevance Health forecast:

Buy
77%
Hold
18%
Sell
5%

Financial data from Elevance Health

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
174,015 174,015
3% 3%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 37,993 37,993
9% 9%
22%
- Research and Development Expense - -
-
-
- -
-
-
- Depreciation and Amortization 1,419 1,419
21% 21%
1%
EBIT (Operating Income) EBIT 9,202 9,202
3% 3%
5%
Net Profit 6,418 6,418
6% 6%
4%

In millions USD.

Don't miss a Thing! We will send you all news about Elevance Health directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Elevance Health Stock News

Neutral
GlobeNewsWire
8 days ago
SAN DIEGO, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether Elevance Health, Inc. (NYSE: ELV) or any of its executive officers violated securities laws by misrepresenting or failing to timely disclose material information to investors. The investigation focuses on investors' losses and whether they may be recovered under federal securiti...
Neutral
Seeking Alpha
11 days ago
Elevance Health, Inc. (NYSE:ELV ) UBS Global Healthcare Conference November 12, 2024 10:15 AM ET Company Participants Mark Kaye - Executive VP & CFO Conference Call Participants A.J. Rice - UBS A.J.
Neutral
GlobeNewsWire
19 days ago
SAN DIEGO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether Elevance Health, Inc. (NYSE: ELV) or any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focuses on investors' losses and whether they may be recovered und...
More Elevance Health News

Company Profile

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Commercial and Specialty Business, Government Business, CarelonRx, and Other. The Commercial and Specialty Business segment provides insurance products and services such as stop loss, dental, vision, life, disability and supplemental health insurance. The Government Business segment includes medicare and medicaid businesses, national government services, and services provided to the federal government. The CerelonRx segment offers formulary management, pharmacy networks, prescription drug database, member services, and mail order capabilities. The Other segment is involved in health services business focused on quality of healthcare by enabling and creating new care delivery and payment models. The company was founded in 1944 and is headquartered in Indianapolis, IN.

Head office United States
CEO Gail Boudreaux
Employees 104,900
Founded 1944
Website www.elevancehealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today